EUVIMEDOpdag EUVIMED
Crossref

β‐Sitosterol attenuates anlotinib resistance in non‐small cell lung cancer cells by inhibiting miR ‐181a‐3p/ SHQ1 signaling

Li-Huai Wang, Yin-Hui Sun, Hua Liu, Xiao Yang, Zhi Wen, Xue-Fei Tian

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14493 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2024. Written by Li-Huai Wang and 5 co-authors. Institution: Graduate School of Hunan University of Traditional Chinese Medicine, Changsha, Hunan, P.R. China. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Indoles, Lung Neoplasms, MicroRNAs. Cited 8 times so far (Crossref); 37 references. Funded by: Research Fund of Hunan University of Chinese Medicine (2020XJJJ033), Natural Science Foundation of Hunan Province (2021JJ30523), Hunan Clinical Research Center of Traditional Chinese Medicine Oncology (2021SK4023).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Anlotinib is used for the treatment of advanced non‐small cell lung cancer; however, the emergence of drug resistance limits its clinical application. β‐sitosterol may also be used to treat lung cancer, but there have been no studies evaluating β‐sitosterol against anlotinib‐resistant lung cancer. The purpose of this study was to determine the mechanism by which β‐sitosterol enhances the sensitivity of lung cancer cells to anlotinib. A549 cells were treated with different concentrations of anlotinib to generate anlotinib‐resistant cells (A549/anlotinib cells). miR‐181a‐3p mimics were transfected into A549/anlotinib cells. A549 and A549/anlotinib cells were treated with β‐sitosterol at various concentrations. The Cell Counting Kit‐8 (CCK‐8) assay was used to measure cell proliferation. Apoptosis was assessed by flow cytometry. Real‐time quantitative PCR was used to measure the expression of miR‐181a‐3p. The interaction of miR‐181a‐3p with the H/ACA ribonucleoprotein assembly factor (SHQ1) was predicted using the miRDB and TargetScan Human databases and verified with a luciferase reporter assay. The expression of SHQ1, activating transcription factor 6 (ATF6), and glucose‐regulated protein 78 (GRP78) were measured by western blot analysis. β‐Sitosterol effectively suppressed A549/anlotinib cell proliferation and promoted apoptosis. SHQ1 is a downstream target of miR‐181a‐3p. The expression of miR‐181a‐3p was inhibited; however, SHQ1 expression was increased by β‐sitosterol treatment of A549/anlotinib cells. The inhibition of SHQ1, ATF6, and GRP78 protein expression by β‐sitosterol in A549/anlotinib cells was rescued by increased miR‐181a‐3p. β‐Sitosterol markedly promotes anlotinib‐resistant A549 cell apoptosis and inhibits cell proliferation by activating SHQ1/UPR signaling through miR‐181a‐3p inhibition.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Non-Small-Cell LungIndolesLung NeoplasmsMicroRNAsQuinolinesSitosterolsHumansEndoplasmic Reticulum Chaperone BiPIntracellular Signaling Peptides and ProteinsDrug Resistance, Neoplasm

Author keywords

AnlotinibSHQ1/UPR signalingapoptosislung cancermiR-181a-3pproliferationβ-Sitosterol

Substances

anlotinibEndoplasmic Reticulum Chaperone BiPgamma-sitosterolIndolesIntracellular Signaling Peptides and ProteinsMicroRNAsQuinolinesSHQ1 protein, humanSitosterolsMIrn181 microRNA, human

Authors and institutions

  • Graduate School of Hunan University of Traditional Chinese Medicine, Changsha, Hunan, P.R. China.
  • The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China.
  • School of Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China.
  • Department of Oncology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China.
  • College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, P.R. China.

Funding

  • Research Fund of Hunan University of Chinese Medicine (2020XJJJ033)
  • Natural Science Foundation of Hunan Province (2021JJ30523)
  • Hunan Clinical Research Center of Traditional Chinese Medicine Oncology (2021SK4023)

Cite

APA

Wang, L. H., Sun, Y. H., Liu, H., Yang, X., Wen, Z., & Tian, X. F. (2024). β‐Sitosterol attenuates anlotinib resistance in non‐small cell lung cancer cells by inhibiting miR ‐181a‐3p/ SHQ1 signaling. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14493

Vancouver

Wang LH, Sun YH, Liu H, Yang X, Wen Z, Tian XF. β‐Sitosterol attenuates anlotinib resistance in non‐small cell lung cancer cells by inhibiting miR ‐181a‐3p/ SHQ1 signaling. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14493

BibTeX
@article{Wang2024,
  author = {Wang, Li-Huai and Sun, Yin-Hui and Liu, Hua and Yang, Xiao and Wen, Zhi and Tian, Xue-Fei},
  title = {β‐Sitosterol attenuates anlotinib resistance in non‐small cell lung cancer cells by inhibiting miR ‐181a‐3p/ SHQ1 signaling},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14493}
}
Start for free →